BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 2887889)

  • 1. Antifertility actions of the progesterone antagonist RU 486 include direct inhibition of placental hormone secretion.
    Das C; Catt KJ
    Lancet; 1987 Sep; 2(8559):599-601. PubMed ID: 2887889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of placental protein 12 and chorionic gonadotrophin following RU 38486 and gemeprost for termination of first trimester pregnancy.
    Olajide F; Howell RJ; Wass JA; Holly JM; Bohn H; Grudzinskas JG; Chapman MG; Chard T
    Hum Reprod; 1989 Apr; 4(3):337-40. PubMed ID: 2715311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
    Gaillard RC; Herrmann W
    Ann Endocrinol (Paris); 1983; 44(5):345-6. PubMed ID: 6675522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Termination of very early pregnancy by RU 486--an antiprogestational compound.
    Kovacs L; Sas M; Resch BA; Ugocsai G; Swahn ML; Bygdeman M; Rowe PJ
    Contraception; 1984 May; 29(5):399-410. PubMed ID: 6744860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility control in women: results with RU 486 by the end of 1985.
    Baulieu E
    J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist.
    Maria B; Stampf F; Goepp A; Ulmann A
    Eur J Obstet Gynecol Reprod Biol; 1988 Jul; 28(3):249-55. PubMed ID: 3208966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trophoblastic and decidual response to RU486: effects on human chorionic gonadotrophin, human placental lactogen, prolactin and pregnancy-associated plasma protein-A production in vitro.
    Bischof P; Sizonenko MT; Herrmann WL
    Hum Reprod; 1986 Jan; 1(1):3-6. PubMed ID: 2458379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone antagonists on the horizon.
    Spitz IM; Bardin CW
    Clin Obstet Gynecol; 1989 Jun; 32(2):403-13. PubMed ID: 2663280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
    Couzinet B; Le Strat N; Ulmann A; Baulieu EE; Schaison G
    N Engl J Med; 1986 Dec; 315(25):1565-70. PubMed ID: 3785321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contragestion by antiprogestin: a new approach to human fertility control.
    Baulieu EE
    Ciba Found Symp; 1985; 115():192-210. PubMed ID: 3849413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
    Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
    Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of differentiated trophoblast function by epidermal growth factor: relation of immunohistochemically detected cellular epidermal growth factor receptor levels.
    Maruo T; Matsuo H; Oishi T; Hayashi M; Nishino R; Mochizuki M
    J Clin Endocrinol Metab; 1987 Apr; 64(4):744-50. PubMed ID: 2434521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified first and third trimester placental trophoblasts differ in in vitro hormone secretion.
    Kato Y; Braunstein GD
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1187-92. PubMed ID: 2318939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy termination with a high and medium dosage regimen of RU 486.
    Shoupe D; Mishell DR; Brenner PF; Spitz IM
    Contraception; 1986 May; 33(5):455-61. PubMed ID: 3757511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
    Bygdeman M; Swahn ML
    Contraception; 1985 Jul; 32(1):45-51. PubMed ID: 4053605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of anti-progesterones as a medical IUD.
    Nieman LK; Loriaux DL
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to human fertility control: contragestion by the anti-progesterone RU 486.
    Baulieu EE
    Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):125-9. PubMed ID: 3402651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
    Thong KJ; Norman JE; Baird DT
    Br J Obstet Gynaecol; 1993 Dec; 100(12):1111-4. PubMed ID: 7507707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility control with RU 486.
    Ulmann A; Dubois C; Philibert D
    Horm Res; 1987; 28(2-4):274-8. PubMed ID: 3331378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.